Eli Lilly’s recently acquired manufacturing facility in Pleasant Prairie, WI, which it’s expanding with a $3 billion investment (Kyle LaHucik for Endpoints News)
December 5, 2024 03:30 PM ESTUpdated 04:30 PM
Pharma
Manufacturing

Lil­ly con­tin­ues to ex­pand its em­pire of GLP-1 fac­to­ries with new $3B build­out

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

PLEAS­ANT PRAIRIE, WI — A four-minute dri­ve north of the Illi­nois-Wis­con­sin bor­der in “Amer­i­ca’s Dairy­land,” Eli Lil­ly is stak­ing one of its largest-ever man­u­fac­tur­ing bets to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Cal­i­co, De­nal­i's ALS drugs miss pri­ma­ry ob­jec­tives in bas­ket study

Ver­tex signs in vi­vo gene edit­ing de­liv­ery pact for sick­le cell and tha­lassemia as it looks be­yond Cas­gevy

Met­sera’s long-act­ing GLP-1 looks com­pet­i­tive in Phase 2 obe­si­ty study

Ex­clu­sive: Aven­zo picks up an­oth­er ADC, this time with mul­ti-part­nered Du­al­i­ty­Bio

Ken Song's Can­did li­cens­es a T cell en­gager from WuXi Bio

Every FDA drug ap­proval from 2024: Few­er nods, but long-await­ed treat­ments cross the fin­ish line

A service from the Financial Times